Generative AI’s Technology Is Not Yet Fully Optimized for Healthcare
Summary
Generative artificial intelligence (AI) faces many growing pains as it seeks its footing. In a recent survey, management consulting firm Bain & Company reveals that the main barriers to generative AI in healthcare are a lack of resources, expertise and regulation, with data access and quality and organizational resistance close behind. The recurring theme across industry studies is that generative AI in healthcare is nascent and needs time to prove its efficacy and to earn public trust. Robust benchmarks will increase confidence. The lesson for technology companies, pharmaceutical firms and healthcare providers considering generative AI in their strategies is that the technology is not yet fully optimized for healthcare. For generative AI to bear fruit, it needs investors, technology, resources, expertise, LLMs trained with healthcare-specific data, and robust guidelines. Ultimately, society needs to be ready for and comfortable with the involvement of generative AI in managing patient health and treatment. The task ahead entails expanding resources and expertise, training models on healthcare-specific data and establishing robust benchmarks. In time, through multiple iterations, generative AI will sharpen its analysis. Developers will fine-tune the benchmarks and criteria used in their models, aligning them with emerging regulatory guidelines. The result will be improved accuracy in diagnoses and recommended treatments. Ethical guidelines and human readiness will shape generative AI use and governance. Regulators are urged to move fast, but doing so too quickly could bring unintended consequences. The same caution applies to technology companies that are eager to earn a profit from their innovations. AI tools that gain FDA approval are setting a precedent for what will become commonplace in the future. The potential downside may be that ethical dilemmas will prompt companies and regulators to reconsider their positions. According to a recent study, Americans have mixed feelings about the use of generative AI in their healthcare. While they are enthusiastic about the potential benefits, most Americans are hesitant to replace their medical professionals with this technology. These sentiments may shift over time as technology matures and regulatory guidelines become more robust.The post Generative AI’s Technology Is Not Yet Fully Optimized for Healthcare first appeared on PYMNTS.com.
The Clearing House’s RTP network and The Fed's FedNow network are prepared to tackle interoperability eventually — but for now, its value remains minimal.
FedNow, RTP interoperability is inevitable — down the line
Digital Currencies
Summary
The Clearing House’s RTP network and The Fed's FedNow network are prepared to tackle interoperability eventually — but for now, its value remains minimal.
The post Solana Struggles Amid Intense Bearish Pressure at Resistance Lines: What’s Next for SOL Price appeared first on Coinpedia Fintech News Solana pri…
Solana Struggles Amid Intense Bearish Pressure at Resistance Lines: What’s Next for SOL Price
Blockchain · Digital Currencies
Summary
The post Solana Struggles Amid Intense Bearish Pressure at Resistance Lines: What’s Next for SOL Price appeared first on Coinpedia Fintech News Solana price has been declining steeply following the SEC’s approval of spot Ethereum ETFs. For example, the SOL/ETH pair, which is closely monitored, has dropped by 16.8% since May 17 following the U.S. Securities and Exchange Commission’s (SEC) request for Ether ETF applicants to revise their 19b-4 filings. Additionally, there’s a decline in activity in the SOL ecosystem, suggesting further bearish pressure on the edge. Analysts Expect SOL ETF By 2025 Solana might be losing its momentum to Ethereum following SEC’s approval of spot ETH ETF. However, analysts believe that Solana is not far from having its own ETF. Geoffrey Kendrick, an analyst at Standard Chartered, predicts that SOL and XRP ETFs could receive approval by 2025. Kendrick suggests that the recent approval of the ETH ETF implies that Ether and altcoins may not be classified as securities. Analysts from The Birb Nest have observed that discussions around a Solana ETF are surging on crypto Twitter and in media circles, indicating that it’s likely to happen. The total value locked (TVL) within the Solana ecosystem experienced a notable decline in May. As of May 23, there were 27.48 million SOL locked, down from the monthly peak of 29.4 million SOL. This decline in Solana’s TVL was particularly sharp after May 20, following reports on the potential approval of spot Ether ETFs. On that date, the TVL was recorded at 28.3 million SOL, suggesting that the news about the Ether ETFs might have triggered the withdrawals from the Solana ecosystem. Since the Ethereum ETF approval on May 20, Solana node validators started rapidly withdrawing funds. Initially holding 368.8 million SOL in staking contracts, they withdrew 3.5 million SOL by May 24, reducing the active staking to 365.3 million SOL. Also read: Analyzing the Effect of Approval of Ethereum ETF on Solana: Market Trends and Price Prediction With Solana’s current price at $167, these unstaked SOL are valued at approximately $580 million. Such significant withdrawals from a Proof-of-Stake (PoS) network generally lead to short-term price declines. What’s Next For SOL Price? Solana price failed to break above $190 as sellers strongly defended a surge above that level, resulting in a steep decline below immediate Fib channels. SOL price dropped below its EMA trend lines too; however, buyers defended further drops below $160. As of writing, SOL price trades at $166, declining over 4% in the last 24 hours. SOL price is struggling to surpass the EMA20 trend line, indicating continued bearish pressure at higher levels. The declining EMA trend lines and the RSI level heading toward the oversold region suggest a rising dominance in bearish positions. Should buyers push past the descending resistance line, the SOL/USDT pair might aim to retest the significant resistance at $192. A break above this level might send the SOL price toward $210.
The Securities and Exchange Commission (SEC) is poised to green-light Ethereum (Ether) ETFs after years of pushback. As of this writing, it was not clear …
Digital Currencies · Banking Infrastructure · Blockchain
Summary
The Securities and Exchange Commission (SEC) is poised to green-light Ethereum (Ether) ETFs after years of pushback. As of this writing, it was not clear as
Services: Binance, YouHodler, Digital Asset, Lolli, Ethereum, Coinbase, Bitcoin